Vaccine Design and Testing – Multimedia

Download this listicle to explore the uses of ELISAs in clinical diagnostics and epidemiology, biopharmaceutical and vaccine development, food safety analysis, environmental analysis and forensics.

This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.

From mRNA vaccines to RNA interference (RNAi) and beyond, discover how RNA therapeutics are reshaping the landscape of genetic medicine.

In this interview, Dr. Katalin Karikó talks about discovering she had won the Nobel Prize for discoveries that accelerated the introduction of vaccines for COVID-19. She recalls her journey and some of the setbacks on the path to the mRNA vaccines.

This application note demonstrates the successful identification of two low-abundance monoclonal antibodies using next-generation protein sequencing.

The pandemic has ushered in a vaccine “golden era”. Long-term investment in vaccine manufacturing has been prioritized, as has the pursuit of novel vaccine platforms. We explore recent advances in vaccine research and development.

This eBook highlights ways that you can level up your vaccine research with selected bioreactor tools to fit your vaccine development workflow.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.

Increased demand has led to an overwhelming volume of LC-MS/MS data and a requirement for analytical software that can simplify its interpretation. This poster highlights a new, comprehensive software solution capable of eliminating the otherwise overwhelming efforts of manual data interpretation.

Lipid nanoparticles (LNPs) have emerged as effective delivery vehicles for mRNA vaccines and nucleic acid-based drugs. Hence, the analysis of their composition, stability, and biological interactions is essential in drug development and delivery.